Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
CANC
54
HOLDINGS
24%
ALSO IN BBP
BBP
68
HOLDINGS
22%
ALSO IN CANC
SECTOR DRIFT (CANC minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
HALOZYME THERAPEUTICS INC | 3.1% | 2.4% | 2.4% |
|
BEIGENE LTD. SPONSORED ADR | 4.1% | 1.8% | 1.8% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.7% | 2.7% | 1.7% |
|
AMGEN INC | 1.9% | 1.7% | 1.7% |
|
EXELIXIS INC | 3.7% | 1.7% | 1.7% |
CANC Overweight Relative to BBP
 |
GENMAB A/S SPONSORED ADR | 5.9% |
|
REVOLUTION MEDICINES, INC. | 5.8% |
|
ELI LILLY & CO | 5.2% |
|
MERCK & CO. INC. | 4.9% |
|
COGENT BIOSCIENCES INC | 4.7% |
 |
NOVARTIS AG | 4.2% |
|
ABBVIE INC | 3.7% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 3.1% |
|
CG ONCOLOGY, INC. | 2.9% |
|
ENLIVEN THERAPEUTICS, INC. | 2.7% |
CANC Underweight Relative to BBP
|
MODERNA, INC. | -5.8% |
|
OMEROS CORP | -2.7% |
|
XERIS PHARMACEUTICALS INC | -2.0% |
|
INTREXON CORP | -2.0% |
|
REGENERON PHARMACEUTICALS | -2.0% |
|
ADMA BIOLOGICS, INC. | -1.8% |
|
PROTAGONIST THERAPEUTICS, INC. | -1.7% |
|
ARCUTIS BIOTHERAPEUTICS INC | -1.7% |
|
BIOGEN IDEC INC | -1.6% |
|
LIGAND PHARMACEUTICALS-CL B | -1.6% |